• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS TESTOSTERONE II ASSAY; RADIOIMMUNOASSAY, TESTOSTERONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS TESTOSTERONE II ASSAY; RADIOIMMUNOASSAY, TESTOSTERONE Back to Search Results
Catalog Number 07027915190
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/09/2019
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).The sample was requested for investigation.
 
Event Description
The initial reporter complained of discrepant high results for 1 patient tested for elecsys testosterone ii (testosterone ii) on a cobas e 801 module compared to the beckman method.The result from the e801 module was > 52 nmol/l.The sample was repeated on the e801 module and the result was the same.The sample was tested by the beckman method and the result was 11.11 nmol/l.The customer suspects an interference affecting the roche results as the patient does not have a condition that would cause elevated testosterone results.The e801 module serial number is (b)(4).
 
Manufacturer Narrative
The patient sample was sent to an external laboratory where the testosterone result from the abbott method was 69.14 nmol/l.This result is comparable to the roche results.A product problem was not identified.
 
Manufacturer Narrative
On (b)(6) 2020 the patient had a testosterone ii result on the e801 module of > 52 nmol/l.On (b)(6) 2020 04-mar-2020 the patient had a testosterone ii result on the e801 module of 37.3 nmol/l.The patient was not taking hyperthyroidism medication at the time of these tests.Section d11 was updated.The sample submitted for investigation is undergoing further testing.
 
Manufacturer Narrative
The sample was received for investigation and tested on a cobas e411 and a cobas e801; the customer's results were reproduced: e411: 65.23 nmol/l.E801: 61.25 nmol/l.The sample was tested further to investigate the presence of an interfering factor.An interfering factor was not identified.Based on the investigation results, a general reagent issue was not observed.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS TESTOSTERONE II ASSAY
Type of Device
RADIOIMMUNOASSAY, TESTOSTERONE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key9547182
MDR Text Key217690607
Report Number1823260-2020-00030
Device Sequence Number1
Product Code CDZ
Combination Product (y/n)N
PMA/PMN Number
K093421
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup,Followup
Report Date 04/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/03/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2019
Device Catalogue Number07027915190
Device Lot Number353224
Was Device Available for Evaluation? Yes
Date Manufacturer Received12/10/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AMOXICILLIN.
Patient Age57 YR
-
-